Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Mutation Analysis of IgVH Genes in Splenic Marginal Zone Lymphomas: Correlation with Clinical Characteristics and Outcome

CHRISTINA KALPADAKIS, GERASSIMOS A. PANGALIS, EVANGELIA DIMITRIADOU, MARIA K. ANGELOPOULOU, MARINA P. SIAKANTARIS, MARIE-CHRISTINE KYRTSONIS, MARIA XIMERIS, TATIANA TZENOU, SOTIRIOS SAHANAS, XANTHI YIAKOUMIS, ELENI A. PAPADAKI, PANAYIOTIS PANAYIOTIDIS and THEODOROS VASSILAKOPOULOS
Anticancer Research May 2009, 29 (5) 1811-1816;
CHRISTINA KALPADAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERASSIMOS A. PANGALIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pangalis{at}med.uoa.gr
EVANGELIA DIMITRIADOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA K. ANGELOPOULOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARINA P. SIAKANTARIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIE-CHRISTINE KYRTSONIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA XIMERIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TATIANA TZENOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOTIRIOS SAHANAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XANTHI YIAKOUMIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELENI A. PAPADAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PANAYIOTIS PANAYIOTIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THEODOROS VASSILAKOPOULOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 5 1811-1816
PMID 
19443409

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 31, 2008
  • Revision received February 18, 2009
  • Accepted March 11, 2009
  • Published online May 13, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. CHRISTINA KALPADAKIS1,2,*,
  2. GERASSIMOS A. PANGALIS1,
  3. EVANGELIA DIMITRIADOU1,
  4. MARIA K. ANGELOPOULOU1,
  5. MARINA P. SIAKANTARIS1,
  6. MARIE-CHRISTINE KYRTSONIS1,
  7. MARIA XIMERIS2,
  8. TATIANA TZENOU1,
  9. SOTIRIOS SAHANAS1,
  10. XANTHI YIAKOUMIS1,
  11. ELENI A. PAPADAKI2,
  12. PANAYIOTIS PANAYIOTIDIS1 and
  13. THEODOROS VASSILAKOPOULOS1
  1. 1Department of Haematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens
  2. 2Department of Haematology, University of Crete, University Hospital of Heraklion, Crete, Greece
  1. Correspondence to: Gerassimos A. Pangalis, MD, Professor of Haematology, 1, Kyriakidou Str, P. Psychicon, 15452, Attica, Greece. Tel: +30 6973638873, Fax: +30 2106748812, e-mail: pangalis{at}med.uoa.gr
View Full Text

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
  • Back Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mutation Analysis of IgVH Genes in Splenic Marginal Zone Lymphomas: Correlation with Clinical Characteristics and Outcome
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mutation Analysis of IgVH Genes in Splenic Marginal Zone Lymphomas: Correlation with Clinical Characteristics and Outcome
CHRISTINA KALPADAKIS, GERASSIMOS A. PANGALIS, EVANGELIA DIMITRIADOU, MARIA K. ANGELOPOULOU, MARINA P. SIAKANTARIS, MARIE-CHRISTINE KYRTSONIS, MARIA XIMERIS, TATIANA TZENOU, SOTIRIOS SAHANAS, XANTHI YIAKOUMIS, ELENI A. PAPADAKI, PANAYIOTIS PANAYIOTIDIS, THEODOROS VASSILAKOPOULOS
Anticancer Research May 2009, 29 (5) 1811-1816;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Mutation Analysis of IgVH Genes in Splenic Marginal Zone Lymphomas: Correlation with Clinical Characteristics and Outcome
CHRISTINA KALPADAKIS, GERASSIMOS A. PANGALIS, EVANGELIA DIMITRIADOU, MARIA K. ANGELOPOULOU, MARINA P. SIAKANTARIS, MARIE-CHRISTINE KYRTSONIS, MARIA XIMERIS, TATIANA TZENOU, SOTIRIOS SAHANAS, XANTHI YIAKOUMIS, ELENI A. PAPADAKI, PANAYIOTIS PANAYIOTIDIS, THEODOROS VASSILAKOPOULOS
Anticancer Research May 2009, 29 (5) 1811-1816;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy
  • Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group
  • Google Scholar

More in this TOC Section

  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
  • Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
  • Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire